glp 1 withdrawal effects Why do patients stop GLP-1 drugs? A Closer Look at the

The litigation centers on claims that GLP-1 receptor agonistslike Ozempic, Wegovy, and Mounjaroled to serious gastrointestinal injuries, including delayed stomach emptying and intestinal obstruction

Because tirzepatide targets both GLP-1 and GIP receptors, researchers are evaluating whether dual agonist therapies may produce even greater functional improvement in obesity-related osteoarthritis

Indianapolis, IN: Eli Lilly and Company

Maintaining a consistent, regular dosing schedule helps support appetite control, blood sugar stability, and steady progress toward significant weight loss goals.

Endocrinology (2009) 150:171222